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Abstract
We have developed a neural network potential energy function for use in drug dis-
covery, with chemical element support extended from 41% to 94% of druglike molecules
based on ChEMBL.1 We expand on the work of Smith et al.,2 with their highly ac-
curate network for the elements H, C, N, O, creating a network for H, C, N, O, S,
F, Cl, P. We focus particularly on the calculation of relative conformer energies, for
which we show that our new potential energy function has an RMSE of 0.70 kcal/mol
for prospective druglike molecule conformers, substantially better than the previous
state of the art. The speed and accuracy of this model could greatly accelerate the
parameterization of protein-ligand binding free energy calculations for novel druglike
molecules.
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1 Introduction
Neural network potential energy functions, promising quantum accuracy at classical cost,
are an exciting prospect for computational chemists. Research has been especially intense
since 2017, when Smith et al.3 introduced the ANI family of neural networks. The two most
recent, ANI-1x and ANI-1cc, have proved strikingly accurate on the Genentech rotamer
benchmark,4 a proxy for crucial drug discovery methods like conformer search and force
field parameterization. However, use of ANI models in drug discovery applications has so
far been limited. While the Genentech test set results are good, larger and more diverse
molecules remain a problem for ANI. The chemical elements covered by ANI to date are
limited to H, C, N, O, which means for example that only 41% of the ChEMBL database1
is covered, as shown in Figure 1. Furthermore, as noted by Smith et al., the ANI models to
date are trained with very limited rotamer data, which ultimately puts a limit on rotamer
accuracy.5 The opportunity is clear: to create a model retaining the advantages of ANI, but
with chemical and geometric coverage commensurate to the challenges of drug discovery.
Figure 1: Cumulative ChEMBL1 coverage for its top ten most common elements. We
selected the subset H, C, N, O, S, F, Cl, P based on this analysis and our experience with
drug discovery projects.
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2 Model Architecture
Our Schro¨dinger-ANI model architecture is an extension of the ANI-1 neural network design
by Smith et al.2 The inputs are atomic Cartesian coordinates x, y, and z, and the element
a, for each atom to be considered. The atomic coordinates are passed through radial and
angular basis functions to form local atomic environment vectors (AEVs),6 one AEV per
atom, as shown in Figure 2.
Figure 2: The structure of AEV neural network inputs for HCNO, showing radial and angular
basis functions as r and θ respectively. For brevity, most angle combinations are omitted.
Each AEV is a compression of the relevant information about one atom and its local
environment, sufficient to predict its atomic energy. The compression is, in computer sci-
ence terms, lossy - it is not generally possible to reconstruct the Cartesian coordinates of
a molecule from the AEVs. The benefit of the compression is that very little extraneous
information is left, either. Part of the success of the AEV input is that it guarantees key
physical properties - locality, rotational invariance, translational invariance, and atom order
invariance - by discarding any input information which could violate these properties. A
flaw in the AEV method is that the total feature size increases as the cube of the number
of chemical elements supported: each new element requires its own set of AEVs, and the
length of each AEV further increases as the square of the number of elements. Some have
suggested that this scaling will prevent AEVs from being used with larger numbers of ele-
ments.7 However, for eight elements, the larger featurization is not a barrier in practice, as
we demonstrate. Eight elements is enough to cover 94% of the ChEMBL database,1 and
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99% of the chemical matter of our internal and collaboratively pursued small molecule drug
discovery projects.
The mapping between AEVs and atomic energies is performed by dense neural networks,
one for each element. The incoming atoms are sorted by element, passed through the ap-
propriate networks, and their resulting atomic energies are summed, as shown in Figure
3.
Figure 3: The ANI-1 neural network architecture.3 A molecule with multiple elements (water,
in this example) is processed by splitting its atoms by element, calculating the AEV for each
atom, predicting the energy for each AEV, and summing the results.
The neural network activation function, as in ANI-1x, is CELU (Continuously-differentiable
Exponential Linear Unit)8 with α = 0.1. Each hidden layer in the neural network xi is cal-
culated from the previous layer xi−1 using a weight matrix W and bias vector b, as follows:
xi = CELU(xi−1W + b, 0.1) (1)
CELU(x, α) =

x if x ≥ 0
α
(
exp( x
α
)− 1) if x < 0 (2)
CELU is a good choice because it results in fast training, like the ReLU (Rectified Linear
Unit) function it approximates, but differs from ReLU by producing an output with contin-
uous gradients, and thus an energy surface with continuous atomic forces. We initialized the
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weights for each network using Xavier initialization,9 and employed max-norm regulariza-
tion10 at each weight update, with max-norm = 3. Besides the use of AEVs and a smooth
activation function, the neural networks do not encode any explicit physical principles. The
physics of the model is learned from the training set of geometries with known Density
Functional Theory (DFT) energies.
Ensembles of neural networks are typically more accurate than a single network, and
Smith et al. showed that this holds true for neural network potential energy surfaces.2 Our
final Schro¨dinger-ANI is an ensemble of six of the above-described models, each trained with
a different random seed, and using the mean over the ensemble for both energies and atomic
forces. The median would be more robust, since it can tolerate outliers, but the median
does not have a continuous gradient and thus would produce discontinuous forces. As with
ANI-1x, in this work we used equal weights for all ensemble members when taking the mean
(a procedure known as bootstrap aggregating or bagging).2,11
3 Dataset Construction
We differed from Smith et al.2 in our approach to dataset construction. The ANI-1x approach
consists of exhaustive enumeration of small HCNO compounds using the GDB dataset,12
followed by geometry sampling using normal mode analysis, and finally active learning to
prune and enhance the resulting dataset.2,13
The ANI-1 approach to sampling has several inefficiencies. The dense sampling of chemi-
cal space provided by GDB is barely feasible for HCNO,12 and becomes combinatorially more
difficult when used with more elements. Meanwhile, normal mode sampling for geometries
tends to oversample small perturbations around the minima, while missing other relevant
geometries. These sampling problems with the ANI-1x approach can be mitigated using ac-
tive learning, which will converge eventually to an information-rich dataset. However, given
that we have some knowledge already about sampling druglike molecule conformers, it is
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more efficient to do this from the start.
We need to concentrate our resources on relevant parts of chemical space in order to
handle H, C, N, O, S, F, Cl, and P. Given eight elements, one can hypothesize a vast range
of molecules, but most will be outside of feasible chemical space, so huge savings can be
made by targeting the sample on a feasible subset. We started from Smith et al.’s ANI-1x
dataset, and then sampled chemical space for the newly added elements S, F, Cl, P using
aggregated datasets of commercially available druglike compounds and our internal database
of druglike rotamers. The ANI-1x dataset was entered unchanged at the start, as was our
internal rotamer dataset. We then drew molecules at random from commercially purchasable
sets with a distribution biased toward smaller molecules:
P(sample) ∝ exp
(−Natoms
20
)
(3)
For all resulting molecules larger than 30 atoms, we fragmented the molecule using the
Schro¨dinger Force Field Builder, selecting a random bond and then taking the smallest
substructure that could represent the neighborhood of that bond (typically 15-30 atoms).
More information about the fragmenting scheme and the Schro¨dinger Force Field Builder
can be found in the paper “OPLS3e: Extending Force Field Coverage for Drug-Like Small
Molecules”.14 In our chemical sampling, we deliberately did not filter for chemical redun-
dancy (for example, rejecting new primary amines because we already have one). Instead,
we relied on a later filtering stage.
Once we estimated that we had enough samples from chemical space - 100,000 unique
molecules - we sampled the geometries of these molecules. We generated the initial 3D struc-
ture for each molecule using Schro¨dinger Fast3D, a heuristic-based 3D conformer generator.
We then performed global and local geometry sampling for each molecule. The global sam-
pling algorithm consists of rotating each of the single bonds in each molecule, by an angle
drawn from a uniform random distribution 0-360◦. These samples were optimized, with each
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rotation constrained to its randomly chosen value, using the OPLS3e force field.14 We did
not sample ring flipping or long-range interatomic degrees of freedom. After generating 50
global geometry samples per molecule, we then sampled 10 local perturbations about each
one. The perturbations for bonds, angles, double bond rotations, and improper torsions
were sampled from normal distributions with σ = 0.05 A˚, 5◦, 5◦, and 10◦ respectively. These
local perturbations serve much the same function as normal mode sampling - since we know
the bonds, angles, torsions, etc, which typically define the normal modes, we can skip the
frequency calculation without losing substantial coverage in our sampling. To make sure
that we did not miss other modes, we also sampled Cartesian space, adding Gaussian noise
with σ = 0.05 A˚ on top of our other local sampling for each datapoint.
The resulting geometric samples contain a great deal of information, but much of it
concerns unstable high-energy conformers, which would be wasteful to analyze with our
reference level of DFT. To concentrate the data in more relevant regions, we applied a
very loose geometry optimization using the semi-empirical quantum chemistry method PM7
implemented in the program MOPAC 2016.15 The PM7 model chemistry is not accurate
enough to be used as final training data, but we only need approximate correctness in
order to bias the sampling roughly towards lower-energy states. The convergence criterion
we chose was a root mean squared force of 200 kcal/mol/A˚. In the context of molecular
simulation this is an enormous force, unlikely to be reached often in practical simulations.
However, in the context of random geometry sampling, capping the root mean squared force
at 200 kcal/mol/A˚ gives a great reduction in the range of possible forces, and thus a great
reduction in what Schro¨dinger-ANI has to try to learn. After optimization we removed
obviously redundant geometries - structures with the same atoms and within 10−4 A˚ of each
other in root mean squared atomic positions, after accounting for rotation. In each case of
a pairwise redundancy of this kind we kept the lower-energy of the pair. This left 50 million
datapoints at the PM7 level of theory, for a total CPU cost of less than 100 USD.
We then pruned this dataset for information content using prediction accuracy as a filter.
7
Figure 4: Our sampling workflow.
Using the PM7 energies, we trained five neural networks, each using a random 5% subset
of the data (2.5 million datapoints each). In the ANI-1x active learning process, typically
little or no regularization is used on this type of filtering network, so as to magnify the de-
pendence of each network on its training subset. However, our filtering method is based on
making roughly-accurate median predictions across the dataset, so we trained our filtering
networks using the same hyperparameters as our desired final model, including regulariza-
tion. The error in each median prediction, relative to the known PM7 energy, is then a
sensitive measure of the information content of each datapoint in our setup. Datapoints
that can be accurately predicted using only 5% of the data are clearly low in informa-
tion content, whether in chemical space or geometric space. For our purposes, we don’t
need to know whether the redundancy is chemical or geometric, since our response is the
same either way: exclude the redundant datapoint. We sorted the dataset by the metric
(median prediction error)/
√
Natoms, similar to the active learning criterion in ANI-1x, and
set aside the half of our dataset which had the lower scores. Filtering in this way is more
costly than filtering by chemical heuristics, but also much more closely related to our real
target: information content with respect to our reference level of DFT. Semi-empirical cal-
culations are less than 1% as costly as our reference DFT: ∼0.3 CPU-seconds/datapoint vs
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over 30 CPU-seconds/datapoint, respectively. Therefore, inasmuch as semi-empirical filter-
ing allows a more efficient DFT reference dataset, it has the potential to substantially reduce
our total costs.
From the 25 million highest-information datapoints, we selected 10 million random data-
points for DFT evaluation, biasing toward smaller molecules: P(point) ∝ exp(−Natoms/20).
More datapoints can be computed in the same amount of computer time using smaller sys-
tems, because of the ∼N2.5 scaling of DFT. This selection was over individual geometries,
not molecules, so it is not redundant with the previous steps, which performed size-weighted
sampling over chemical space molecule-by-molecule.
We performed the 10 million single-point DFT calculations on cloud CPU resources using
Schro¨dinger’s DFT engine Jaguar,16,17 in just a few days and at a very reasonable compute
cost. For each molecule, to improve the baseline energies, we also applied DFT geometry
optimization to the geometry with the lowest PM7 energy. We set the convergence tolerance
very loose, at 10 kcal/mol/A˚, since we do not need a precise minimum: we just want to avoid
missing the minimum completely. All of the other geometries were evaluated as single-point
energies. The level of theory used was similar to that in ANI-1x, ωB97X-D/6-31G*,18 the
only difference being that we used the empirical dispersion correction (-D) while ANI-1x did
not. We used Jaguar’s default SCF convergence criteria and DFT quadrature grid, and we
applied the pseudospectral approximation with Jaguars default settings to make calculations
faster.16
4 Training
We first divided the DFT datapoints into training and validation sets. The goal of the
validation set is to be a measure of overfitting, to allow early stopping when overfitting is
observed, and the validation set fulfills this role better when it is less correlated with the
training set (while still being a useful sample of the underlying reality we are trying to learn).
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We achieved this independence by splitting the training and validation sets according to
molecule size, with systems over 24 atoms becoming validation data (about 5% of the total).
In this we differed from ANI-1x, which was trained with a simple uniform random 80/20
train/validation split across all datapoints.13 The problem with the random split across all
datapoints is that many molecules will be found in both the training and validation sets,
differing only by conformation. This means that overfitting of these molecules may not be
detected soon enough, because the validation error will continue to trend downward even if
these molecules are overfitted. Splitting by molecule size means that a given molecule cannot
appear in both sets, though similar substructures are still possible.
Compared to a random split across all molecules, independent of size, the size-dependent
split also has the benefit of making the average molecule in the training set smaller, which
makes training faster. Backpropagation in our neural network training necessarily divides
the error signal for each molecule by the number of atoms in that molecule, which degrades
the training speed as molecule size grows. This is not a problem for the validation set, since
backpropagation is never applied to it. Therefore the most efficient method is to put smaller
molecules in the training set, and larger ones in the validation set, as we have done.
Our loss function differed from that of Smith et al. in that we weighted each datapoint’s
squared error by a Boltzmann-inspired function of its energy, so that low-energy datapoints
(stable configurations) would be treated as more important, and high-energy datapoints
would not dominate the fitting. Our weights were wi = exp(−Ei/(NatomskT )), where Ei is
the energy (after subtracting the self-energy as in Smith et al.5) and kT is 0.006 Hartree,
approximately the standard deviation of Ei over the dataset. We clipped the weights to the
range [0.01, 1.0], so that no datapoint would be ignored entirely.
We trained our ensemble of six models with slightly varying settings, so as to decrease
their correlation and increase the ensemble accuracy. Three of the models were trained
with run-time data augmentation, and three with the plain dataset. The run-time data
augmentation was performed using a new technique, which we call gradient fuzzing. We
10
define gradient fuzzing as generating a random vector ∆x for each training datapoint in
each batch, perturbing the Cartesian coordinates by adding this vector, and then using the
DFT energy gradient δE/δx to adjust the training energy by the corresponding amount ∆E:
∆E = ∆x · δE
δx
(4)
Training with gradient fuzzing produced slightly better validation errors than training
with the un-augmented dataset: 1.20-1.21 kcal/mol for each neural network with fuzz, vs
1.21-1.23 kcal/mol for each network without fuzz. However, it is questionable whether this
procedure is worth the added cost of computing the DFT gradient during the creation of
the reference data. By not calculating the gradient over the reference data, we would be
able to create more reference data. For our application, more energy datapoints might be
better than runtime data augmentation via gradients. In applications where the gradient
calculation is less costly, fewer datapoints are available in total, or the reference systems are
larger, calculating the gradient for each reference datapoint begins to make more sense.
5 Results
Our definition of root mean squared error (RMSE) for relative conformer energies is:
RMSE(molecule) =
√∑ (EDFT,rel − ENN,rel)2
Npoints − 1 (5)
where EDFT,rel and ENN,rel for a molecule are defined such that they are both zero for
the reference conformer, which we choose to be the conformer with the lowest DFT energy.
Npoints − 1 is used in the denominator instead of Npoints because the reference conformer
has zero error in its relative energy by definition: therefore the true number of degrees of
freedom in the relative-energy RMSE is Npoints − 1.
First we examined the Genentech rotamer test set of Sellers et al.,4 which consists of
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rotamers from 62 small druglike molecules. The HCNO molecules from the Genentech set
were used by Smith et al. in evaluating ANI-1x, but for Schro¨dinger-ANI we were able
to evaluate the full set, since its composition is entirely within H, C, N, O, S, F, Cl, P.
Schro¨dinger-ANI showed an RMSE of 0.38 kcal/mol on the Genentech set with single-point
energies relative to our reference level of theory, ωB97X-D/6-31G*. Note that Smith et al.
report the median over rotamer Mean Absolute Deviations, whereas we prefer the mean
rotamer RMSE because it shows outliers more clearly. We know from Smith et al.5 that
ANI-1x is highly accurate for the HCNO subset of the Genentech test set, and we confirm
this, with a mean rotamer RMSE of 0.50 kcal/mol for single-point energies relative to its
reference level of theory, ωB97X/6-31G*.
Table 1: RMSEs (kcal/mol) of ANI-1x and Schro¨dinger-ANI, each judged relative to its
own reference level of theory (ωB97X/6-31G* and ωB97X-D/6-31G* respectively). Genen-
tech RMSEs are for single-point energies, while missing torsion RMSEs are for geometries
optimized with the respective model.
Test set ANI-1x Schro¨dinger-ANI
Genentech (HCNO) 0.50 0.37
Missing torsions (HCNO) 1.07 0.69
Genentech (all) N/A 0.38
Missing torsions (all) N/A 0.70
The Genentech rotamer test set is composed of relatively small molecules - a reasonable
simplification for many purposes, but not representative of the workloads of drug discovery
projects. To evaluate Schro¨dinger-ANI fully, we have to be able to apply it to any druglike
molecule that is proposed. For this reason, we created a more stringent test set, composed
of 1000 molecules drawn uniformly at random from commercially purchasable databases,
excluding molecules with elements outside of H, C, N, O, S, F, Cl, P, and without overlap
from the training set. We evaluated these molecules with the Schro¨dinger Force Field Builder,
removing the “known” torsions (already in our force field database) and isolating the more
unusual torsions that were left. We then sampled these “missing” torsions using the Force
Field Builder, just as a researcher would if using these molecules in a real drug discovery
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project. The result was 6,500 rotamer geometries covering all of the missing torsions.
These rotamers are a strenuous test set, because the molecules are larger than those in
the Genentech set and further outside of normal druglike chemical space (as represented by
the coverage of the OPLS3e force field). Starting from force field geometries, we optimized
the rotamers using both ANI-1x and Schro¨dinger-ANI, while constraining the central torsion
for each molecule. We then analyzed the resulting geometries and energies using DFT single-
point calculations at the correct reference level of theory for each model. The results are
shown in Table 1.
Figure 5: The worst test-set outlier in relaxed rotamer RMSE for Schro¨dinger-ANI, with
an RMSE of 5.2 kcal/mol. The rotated bond is highlighted in green. Even for our worst
molecule, the problem is simply a low barrier - the minima are fairly accurate.
Table 1 shows some N/A entries because ANI-1x cannot be run on the full Genentech
test set, or our full missing torsions test set, due to its element coverage limitation. On the
HCNO subset of the missing torsions set, with geometries relaxed at the ANI-1x level of
theory, ANI-1x has an RMSE of 1.07 kcal/mol relative to its own reference DFT (ωB97X/6-
31G*). Since Schro¨dinger-ANI has an RMSE of 0.70 kcal/mol on the full set relative to
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its reference DFT, this suggests that Schro¨dinger-ANI is significantly more accurate than
ANI-1x for missing torsions, even for the HCNO subset which ANI-1x can handle. Since our
model architectures are essentially identical to ANI-1x for the HCNO subset of elements,
we can only attribute the difference to the geometric and chemical sampling in our dataset.
These comparisons are not to denigrate ANI-1x, but to emphasize the difficulty of the missing
torsions test set, and its suitability as a tough standard for potential energy models. The
largest RMSE outliers for Schro¨dinger-ANI and ANI-1x are shown in Figures 5 and 6.
Figure 6: The worst test-set outlier in relaxed rotamer RMSE for ANI-1x, with an RMSE
of 9.0 kcal/mol. The rotated bond is highlighted in green. The DFT minimum-energy
conformer is mispredicted, causing a high RMSE.
6 Limitations
The most significant limitation of Schro¨dinger-ANI currently is that it will not give correct
absolute energies for systems with non-zero net charge. The geometries and relative energies
may be reasonable for such systems, but the absolute energy will be offset by approximately
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± the ionization energy of the system, because the model has no way of knowing about the
added or removed electron. We are exploring methods which add charge to the feature set.
Another limitation is that Schro¨dinger-ANI (like similar neural networks) is not fast
enough to replace force fields in high-throughput low-latency applications such as molecular
dynamics. The matrix operations used in neural network inference, while very quick com-
pared to DFT integrals, are slow compared to the simple functional forms of bonded force
fields such as OPLS3e. However, since the model can be used to parameterize such force
fields, this limitation is not too burdensome. In particular, the modular parameter structure
of OPLS3e and the Schro¨dinger Force Field Builder would allow easy integration of exist-
ing DFT-based parameters for most torsions, supplemented by new, neural-network-derived
parameters for the rare missing torsions.
7 Conclusions
Our most important conclusion is that our neural network model is accurate enough for
practical applications in drug discovery. Drug discovery employs a funnel-shaped workflow,
in which there are many opportunities for fast, accurate methods at the wide part of the fun-
nel. For force field parameterization, it potentially allows skipping the DFT step entirely in
cases where the highest accuracy is not required. Schro¨dinger-ANI can also be used for con-
formational search, accelerating DFT geometry optimizations, and any other computational
chemistry technique which requires accurate energy and force calculations on the timescale
of tenths of seconds without reparameterization.
The success of this method shows that the ANI architecture continues to deliver on its
promise. Contrary to earlier concerns, the O(N3) scaling of the AEV featurization has not
prevented a doubling of the number of elements covered. It may be infeasible to cover the
entire periodic table in this way, but it is apparently feasible to cover almost all of druglike
chemistry.
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7.1 Tensorflow code
The neural network code used in this paper is proprietary. However, we have released an
earlier version (4 elements) on github: https://github.com/schrodinger/khan
7.2 Neural network architecture
Provided below are the neural network architectures used in this work, by element. The
activation function (used between every pair of layers except the final output node) is CELU
with an alpha of 0.1, as in ANI-1x. Larger networks are used for more common elements,
particularly hydrogen, because more data is available for these elements and thus the risk
of overfitting is less. These networks are relatively narrow and shallow by modern ML
standards, which we found necessary to avoid overfitting. As a bonus, of course, the smaller
networks make inference faster and more efficient.
H: [ 160, 128, 96, 1 ],
C: [ 144, 112, 96, 1 ],
N: [ 128, 112, 96, 1 ],
O: [ 128, 112, 96, 1 ],
S: [ 128, 112, 96, 1 ],
F: [ 128, 112, 96, 1 ],
16
Cl: [ 128, 112, 96, 1 ],
P: [ 128, 112, 96, 1 ],
7.3 Featurization parameters
Provided below are the featurization parameters used in our 8-element neural network. These
are the same as those used in ANI-1x, except that we allow 8 elements.
n_types: 8,
R_Rc: 5.2,
R_eta: 16.0,
A_Rc: 3.5,
A_eta: 8.0,
A_zeta: 32.0,
R_Rs: [
0.9,
1.16875,
1.4375,
1.70625,
1.975,
2.24375,
2.5125,
2.78125,
3.05,
3.31875,
3.5875,
3.85625,
4.125,
4.39375,
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4.6625,
4.93125
],
A_thetas: [
0.19634954,
0.58904862,
0.9817477,
1.3744468,
1.7671459,
2.1598449,
2.552544,
2.9452431
],
A_Rs: [
0.9,
1.55,
2.2,
2.85
],
radial_prefactor: 0.25,
inner_product_prefactor: 0.95
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